Prostate cancer vaccine extends survival in study INO News Tue, 28 Apr 2009 14:02 PM PDT (AP:CHICAGO) An experimental treatment added four months to the lives of men with advanced prostate cancer in a study that tested an entirely new approach to fighting the disease, doctors reported Tuesday. | US can't vouch for cancer assurances to Marines MyMotherLode.com Tue, 28 Apr 2009 14:00 PM PDT In an about-face, the government Tuesday disavowed a 12-year-old federal report that found little or no cancer risk for adults who lived on a Marine base where drinking water was contaminated for three decades. | MOST DISCUSSED ARTICLES Squamish Chief Tue, 28 Apr 2009 13:58 PM PDT HALIFAX, N.S. - Longtime Nova Scotia MP Bill Casey, who has battled both his former party and cancer, has resigned his seat to take on a new job representing his home province's interests in Ottawa. | Emotions, support sway exercise post-breast cancer Reuters via Yahoo! News Tue, 28 Apr 2009 13:54 PM PDT Among women recovering from breast cancer, symptoms of depression are consistently associated with low physical activity, researchers report, while family support appears to reduce declines in physical activity over time. | Acrylamide in food does not up lung cancer risk Reuters via Yahoo! News Tue, 28 Apr 2009 13:53 PM PDT Consumption of foods containing acrylamide does not increase the risk of lung cancer in men, and in women, it may actually reduce the risk. | Ailing Vietnam vet receives national honor Dover Post Tue, 28 Apr 2009 13:50 PM PDT U.S. Army Spec. 4 Glenn LeRoy Martin, was diagnosed three years ago with prostate cancer, which the Department of Veterans Affairs attributes to his wartime exposure to the chemical defoliant Agent Orange. He was was inducted April 24 into the Order of the Silver Rose, sponsored by the non-profit agency of the same name that recognizes Vietnam veterans suffering the effects of Agent Orange. | Dendreon Plunges, and Trades Will Stand TheStreet.com Tue, 28 Apr 2009 13:47 PM PDT A sharp drop in shares of Dendreon minutes ahead of the results of a cancer drug trial prompted an examination by the Nasdaq, but the market said the trades that went through will stand. | Gene alterations associated with response to anthracycline therapy for breast cancer PhysOrg Tue, 28 Apr 2009 13:47 PM PDT Alterations in the topoisomerase II alpha (TOP2A) gene were associated with better patient outcomes following anthracycline-based therapy compared with non-anthracycline-based regimens, according to a study in the April 28 online issue of the Journal of the National Cancer Institute. The increased responsiveness is similar to what is seen in patients whose tumors carry an amplification of the ... | | |
|
No comments:
Post a Comment